Search Results - "Hovels, A"
-
1
Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions?
Published in Clinical pharmacology and therapeutics (01-11-2015)“…An early access pathway of conditional approval for potentially beneficial medicines is available within the European regulatory framework. However, marketing…”
Get full text
Journal Article -
2
Individuals with filaggrin‐related eczema and asthma have increased long‐term medication and hospital admission costs
Published in British journal of dermatology (1951) (01-09-2018)“…Summary Background Eczema and asthma are chronic diseases with onset usually before the age of 5 years. More than 50% of individuals with eczema will develop…”
Get full text
Journal Article -
3
Changing costs of metastatic non small cell lung cancer in the Netherlands
Published in Lung cancer (Amsterdam, Netherlands) (01-12-2017)“…•A Cost of illness study on non-small cell lung cancer is conducted.•Cost on non-small cell lung cancer have decreased in recent years.•Oncolytic drugs have…”
Get full text
Journal Article -
4
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
Published in Clinical radiology (01-04-2008)“…Aim To compare the diagnostic accuracy of computed tomography (CT) and magnetic resonance imaging (MRI) in the diagnosis of lymph node metastases in prostate…”
Get full text
Journal Article -
5
NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
Published in Thrombosis journal (18-04-2018)“…In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral…”
Get full text
Journal Article -
6
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
Published in Breast cancer research and treatment (01-11-2018)“…Purpose Breast cancer is the most common malignancy in women worldwide. Recurrence rates in breast cancer are considered to be dependent on the serum…”
Get full text
Journal Article -
7
-
8
Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity
Published in Atherosclerosis (01-12-2001)“…Low HDL cholesterol increases the risk of coronary heart disease. Treatment of postmenopausal women with tibolone lowers HDL cholesterol. We elucidated the…”
Get full text
Journal Article -
9
Increased medication costs for filaggrin‐related eczema and asthma
Published in British journal of dermatology (1951) (01-09-2018)“…Summary Eczema and asthma are common chronic diseases. Eczema affects 15‐20% of schoolchildren and 2‐10% of adults while asthma affects 16‐18% of the UK…”
Get full text
Journal Article -
10
Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium
Published in European journal of cancer care (01-05-2015)“…Currently, no country‐specific metastatic breast cancer (MBC) observational costing data are available for the Netherlands and Belgium. Our aim is to describe…”
Get full text
Journal Article -
11
Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer
Published in Breast cancer research and treatment (01-06-2013)“…Adequate reflection of disease progression and costs over time is essential in cost-effectiveness analyses based on health state-transition models. However,…”
Get full text
Journal Article -
12
Return on Investment of Preventively Vaccinating Health Care Workers Against Pertussis: A Dutch Case Study
Published in Value in health (01-11-2014)Get full text
Journal Article -
13
治疗丝聚蛋白相关湿疹和哮喘的药物成本增加
Published in British journal of dermatology (1951) (01-09-2018)“…Summary…”
Get full text
Journal Article -
14
PHP111 - The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System
Published in Value in health (01-10-2017)Get full text
Journal Article -
15
The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System
Published in Value in health (01-10-2017)“…OBJECTIVES: The National Health Care Institute (ZIN) advises the minister of healthcare (MOH) if a drug should be reimbursed. Recently it was suggested to…”
Get full text
Journal Article -
16
Metastatic Prostate Cancer and Skeletal Related Events, a Cost of Illness Study
Published in Value in health (01-11-2014)Get full text
Journal Article -
17
Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer
Published in Value in health (01-11-2016)Get full text
Journal Article -
18
PRM105 - Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer
Published in Value in health (01-11-2016)Get full text
Journal Article -
19
Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making
Published in Value in health (01-11-2016)Get full text
Journal Article -
20
PMD118 - Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making
Published in Value in health (01-11-2016)Get full text
Journal Article